Tembexa
Active substance: brincidofovir
SUSPENSION · BRINCIDOFOVIR 10 mg/mL
United StatesActive
Marketing holder: Emergent BioDefense Operations Lansing LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BRINCIDOFOVIR · 10 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-8c34-7d42-b4c6-5dacacab1a09,01a1209d-ddfa-78f4-80c3-2ece4e99ecf1;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 64678-012
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 64678-012 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 64678-012 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 64678-012 · Verified 2026-10-09 · open in source